Skip to main content

. 1979 Apr;7(4):407–410. doi: 10.1111/j.1365-2125.1979.tb00956.x

Plasma half-life of clofibric acid in renal failure.

E M Faed, E G McQueen

PMCID: PMC1429643 PMID: 444361

407

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bagdade J. D. Atherosclerosis in patients undergoing maintenance hemodialysis. Kidney Int Suppl. 1975 Feb;(3):370–372. [PubMed] [Google Scholar]
Faed E. M., McQueen E. G. Serum clofibrate concentrations in patients on continuous medication. Pharmacology. 1974;12(3):144–151. doi: 10.1159/000136532. [DOI] [PubMed] [Google Scholar]
Goldberg A. P., Sherrard D. J., Haas L. B., Brunzell J. D. Control of clofibrate toxicity in uremic hypertriglyceridemia. Clin Pharmacol Ther. 1977 Mar;21(3):317–325. doi: 10.1002/cpt1977213317. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES